Avivagen Inc. (VIVXF)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Breakdown | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -3.11 Million | -4.59 Million | -3.33 Million | -3.52 Million | -3.8 Million | -4.77 Million |
| Net Income | -6.06 Million | -6.39 Million | -4.75 Million | -4.83 Million | -4.83 Million | -5.04 Million |
| Depreciation & Amortization | 87.49 Thousand | 124.77 Thousand | 127.49 Thousand | 4636.00 | 2540.00 | - |
| Deferred income taxes | 105.67 Thousand | 140.76 Thousand | 136.53 Thousand | -23.00 | -2402.00 | - |
| Stock-based compensation | 151.61 Thousand | 326.81 Thousand | 318.8 Thousand | 317.9 Thousand | 575.98 Thousand | 308.16 Thousand |
| Change in working capital | 1.54 Million | -918.48 Thousand | -255.44 Thousand | -1700.00 | -236.55 Thousand | -175.82 Thousand |
| Other non-cash items | 1.05 Million | 2.12 Million | 1.08 Million | 993.51 Thousand | 685.1 Thousand | 140.56 Thousand |
| Investing Cash Flow | - | -8707.00 | -44.29 Thousand | -109.2 Thousand | -69.53 Thousand | - |
| Investments in PPE | - | -8707.00 | -44.29 Thousand | -109.2 Thousand | -69.53 Thousand | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 1.99 Million | 5.34 Million | 2.96 Million | 2.5 Million | 4.48 Million | 1.22 Million |
| Debt repayment | -5.58 Million | -1.22 Million | -64.18 Thousand | -2.03 Million | -91.56 Thousand | -127.79 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 4.02 Million | 7.5 Million | 3 Million | 1.07 Million | 4.05 Million | 1.35 Million |
| Other Financing Activities | 3.55 Million | -923.84 Thousand | 25.54 Thousand | 3.46 Million | 516.85 Thousand | 1.35 Million |
| Accounts receivables | -134.32 Thousand | 172.22 Thousand | -477.61 Thousand | 93.79 Thousand | -127.92 Thousand | -58.27 Thousand |
| Accounts payables | 639.9 Thousand | -228.38 Thousand | 232.01 Thousand | -206.37 Thousand | 262.37 Thousand | 19.93 Thousand |
| Inventory | 219.52 Thousand | -826.01 Thousand | 45.75 Thousand | 127.48 Thousand | -488.58 Thousand | -87.91 Thousand |
| Other working capital | 821.84 Thousand | -36.31 Thousand | -55.59 Thousand | -16.6 Thousand | 252.02 Thousand | -87.9 Thousand |
| Cash at beginning of period | 1.4 Million | 664.16 Thousand | 1.08 Million | 2.2 Million | 1.6 Million | 5.14 Million |
| Cash at end of period | 290.45 Thousand | 1.4 Million | 664.16 Thousand | 1.08 Million | 2.2 Million | 1.6 Million |
| Capital Expenditure | - | -8707.00 | -44.29 Thousand | -109.2 Thousand | -69.53 Thousand | - |
| Effect of forex changes on cash | -399.00 | 4747.00 | -3149.00 | 23.00 | 2402.00 | 2916.00 |
| Net cash flow / Change in cash | -1.11 Million | 744.12 Thousand | -421.77 Thousand | -1.12 Million | 607.25 Thousand | -3.54 Million |
| Free Cash Flow | -3.11 Million | -4.6 Million | -3.37 Million | -3.63 Million | -3.87 Million | -4.77 Million |
| Breakdown | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 FY | 2022 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -932.91 Thousand | -1.24 Million | -1.15 Million | -1.3 Million | -6.06 Million | -1.9 Million |
| Depreciation & Amortization | 5322.00 | 15.34 Thousand | 20.36 Thousand | 20.36 Thousand | 87.49 Thousand | 20.35 Thousand |
| Deferred income taxes | 304.00 | -306.00 | -306.00 | 771.00 | 105.67 Thousand | 399.00 |
| Stock-based compensation | 8646.00 | 16.75 Thousand | 27.82 Thousand | 43.46 Thousand | 151.61 Thousand | 35.64 Thousand |
| Change in working capital | 481.85 Thousand | 808.03 Thousand | 522.35 Thousand | 211.91 Thousand | 1.54 Million | 279.42 Thousand |
| Other non-cash items | 508.3 Thousand | 462.4 Thousand | 453.36 Thousand | 299.4 Thousand | 1.05 Million | 427.35 Thousand |
| Investing Cash Flow | 1.00 | - | - | - | - | - |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | -71.21 Thousand | -67.2 Thousand | -133.76 Thousand | 528.73 Thousand | 1.99 Million | 168.11 Thousand |
| Debt repayment | -9221.00 | -23.41 Thousand | -22.87 Thousand | -12.91 Thousand | -5.58 Million | -155.43 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | 29.53 Thousand | - | 605 Thousand | 4.02 Million | 542.23 Thousand |
| Other Financing Activities | -61.99 Thousand | -73.32 Thousand | -110.88 Thousand | -63.34 Thousand | 3.55 Million | -218.68 Thousand |
| Accounts receivables | 15.85 Thousand | 10.6 Thousand | 498.75 Thousand | -500.37 Thousand | -134.32 Thousand | 135.79 Thousand |
| Accounts payables | 435.03 Thousand | 589.26 Thousand | 9406.00 | 142.01 Thousand | 639.9 Thousand | -83.19 Thousand |
| Inventory | 13.3 Thousand | 53.64 Thousand | 168.43 Thousand | 332.32 Thousand | 219.52 Thousand | 25.49 Thousand |
| Other working capital | 17.67 Thousand | 154.52 Thousand | -154.23 Thousand | 237.95 Thousand | 821.84 Thousand | 201.32 Thousand |
| Cash at beginning of period | 17.18 Thousand | 26.67 Thousand | 290.45 Thousand | 494.8 Thousand | 1.4 Million | 1.46 Million |
| Cash at end of period | 17.18 Thousand | 17.18 Thousand | 26.67 Thousand | 290.45 Thousand | 290.45 Thousand | 494.8 Thousand |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | -304.00 | 306.00 | 306.00 | -771.00 | -399.00 | -399.00 |
| Net cash flow / Change in cash | -6.00 | -9490.00 | -263.77 Thousand | -204.35 Thousand | -1.11 Million | -970.55 Thousand |
| Free Cash Flow | 71.51 Thousand | 57.41 Thousand | -130.32 Thousand | -732.31 Thousand | -3.11 Million | -1.13 Million |
HG
3684
6901
ZOO
CLBK
FAA